• Health
  • Science
  • U.S.
  • Technology
  • Business
  • World
  • Politics
  • Entertainment
  • Sports

Building a Better World

News and information

  • Home
  • Privacy Policy
  • Contact Us
  • Our Team

Breakthrough: Miracle cancer drug could reverse Parkinson’s

October 18, 2015 By Dan Taylor

Breakthrough: Miracle cancer drug could reverse Parkinson’s

It's a huge finding that could change how Parkinson's is treated.

A drug that is typically used to battle leukemia could help people reduce symptoms of Parkinson’s or dementia, a groundbreaking new study has found.

Researchers gave nilotinib, common in the treatment of leukemia, to 12 patients in a pilot study, and found that there was movement and mental improvements in all 11 people who went through with the trial over a period of six months, according to an NPR report. They reported their findings at the Society for Neuroscience meeting in Chicago, which took place this past Saturday.

And they weren’t minor improvements either. The study’s author, Fernando Pagan, who is the director of the Movement Disorders Program at Georgetown University Medical Center, said that one woman actually was able to feed herself again after losing that ability, and another man stopped using his walker. Three more patients who had become mute were suddenly able to speak again. He said it was the “most excited I’ve ever been” in 25 years of Parkinson’s research, according to the report.

It will take some larger studies to prove this result out, however. The treatment will need to go through some placebo-controlled studies, but if these results continue to be seen, nilotinib could be the breakthrough drug Parkinson’s and dementia patients have been waiting for.

Scientists believe that nilotinib may be interrupting the process that results in the death of brain cells, which results in neurodegenerative diseases. This includes diseases like Alzheimer’s.

One of the authors of the study, Charbel Moussa, who is an assistant professor of neurology at Georgetown University, supposedly came upwith the idea to treat people with nilotinib. He knew that many of those with Parkinson’s or dementia often have a related condition: Lewy body dementia. This involves toxic proteins that attack brain cells, and he believed that nilotinib could probably stop this process in its tracks.

Sharing

Facebooktwittergoogle_plusredditpinterestlinkedintumblrmail

Filed Under: Front Page, Health

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow Us

Facebookrss

Search:

Recent Posts

  • NASA’s InSight spacecraft makes important course correction May 26, 2018
  • Scientists outraged at latest Trump decision May 15, 2018
  • Huge uproar erupts over major incident at Utah park May 13, 2018
  • Incredible moon discovery stuns scientists May 12, 2018
  • Authorities shocked by discovery about common painkiller May 6, 2018
  • Outrageous crocodile experiment stuns scientists May 5, 2018
  • Great Barrier Reef is too quiet, scientists say May 1, 2018
  • Massive Hiroshima bomb discovery shocks scientists May 1, 2018
  • Earth will be slammed by massive asteroid April 29, 2018
  • Teens are doing something incredibly alarming in schools April 29, 2018
  • Huge discovery in Tasmania stuns scientists April 28, 2018
  • Shocking discovery in New Jersey stuns authorities April 22, 2018
  • Huge volcanic explosion could wipe out the United States April 21, 2018
  • Huge controversy erupts over world’s hottest pepper April 15, 2018
  • SpaceX is about to do something astonishing April 15, 2018

Copyright © 2022 Jones Kilmartin Group, LLC · Metro Pro Theme On Genesis Framework · WordPress